Table 3.
Histologic lesion scores of lungs from rats receiving endotracheal bleomycin (BL) in the absence (group C) and presence of treatment with N-acetylcysteine (NAC; group D)
| Inflammation | Fibrosis | |||
| Severity | Extension | Severity | Extension | |
| 3 days postexposure | ||||
| Drug vehicle+bleomycin | 2.40±0.24 | 2.20±0.20 | Nil | Nil |
| NAC+bleomycin | 1.80±0.20* | 1.60±0.24* | Nil | Nil |
| 15 days postexposure | ||||
| Drug vehicle+bleomycin | 2.00+0.32 | 2.20±0.37 | 2.40±0.24 | 2.80±0.20 |
| NAC+bleomycin | 1.67±0.21 | 1.83±0.17 | 1.50±0.22* | 2.00±0.26* |
Lung sections from bleomycin-injured rats were coded and then blindly scored for inflammation and fibrosis. Lung inflammation was scored in tissue sections stained with haematoxylin and eosin on a scale of 0 – 4. Lung fibrosis was scored in trichrome-stained sections on a scale of 0 – 4. Data are means±s.e.m. of five to six animals per group.
P<0.05 from the corresponding group exposed to bleomycin without NAC.